Monogram Orthopaedics, Inc. (MGRM)
NASDAQ: MGRM · IEX Real-Time Price · USD
2.170
+0.010 (0.46%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Company Description
Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants.
The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.
Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens.
The company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024.
Monogram Technologies Inc. was founded in 2015 and is headquartered in Austin, Texas.
Monogram Orthopaedics, Inc.
| Country | United States |
| Founded | 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 28 |
| CEO | Benjamin Sexson C.F.A. |
Contact Details
Address: 53 Bridge Street Unit 507 Brooklyn, New York 11201 United States | |
| Phone | (718) 576-3205 |
| Website | monogramorthopedics.com |
Stock Details
| Ticker Symbol | MGRM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001769759 |
| CUSIP Number | 609786108 |
| ISIN Number | US6097861081 |
| Employer ID | 81-2349540 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Benjamin Sexson C.F.A. | Chairman of the Board, President and Chief Executive Officer |
| Dr. Douglas Unis | Founder, Chief Medical Officer and Director |
| Noel Knape CPA, M.B.A. | Chief Financial Officer |
| Dr. Kamran Shamaei Ph.D. | Chief Technology Officer |
| Chris Tyson | Executive Vice President - MZ North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 12, 2024 | 8-K | Current Report |
| Jul 9, 2024 | 424B5 | Filing |
| Jul 1, 2024 | 424B5 | Filing |
| Jun 26, 2024 | 424B5 | Filing |
| Jun 25, 2024 | 424B5 | Filing |
| Jun 14, 2024 | EFFECT | Notice of Effectiveness |
| Jun 11, 2024 | UPLOAD | Filing |
| Jun 4, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Jun 3, 2024 | 1-A-W | Filing |
| May 17, 2024 | 424B3 | Prospectus |